Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc.verified

CRBP

Price:

$10.69

Market Cap:

$134.00M

Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the activation of transforming growth factor ß (TGFß); and CRB-602, an anti-avß6/avß8 mAb that blocks the activation of TGFß for the treatment of fibrotic diseases. The company is also developing cannabinoid receptor type 1 inverse agonist program for the t...[Read more]

Industry

Biotechnology

IPO Date

2014-10-27

Stock Exchange

NASDAQ

Ticker

CRBP

The ROE as of December 2025 (TTM) for Corbus Pharmaceuticals Holdings, Inc. (CRBP) is -43.65%

According to Corbus Pharmaceuticals Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -43.65%. This represents a change of 287.00% compared to the average of -11.28% of the last 4 quarters.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Historical ROE (quarterly & annually)

How has CRBP ROE performed in the past?

The mean historical ROE of Corbus Pharmaceuticals Holdings, Inc. over the last ten years is -160.48%. The current -43.65% ROE has changed -72.80% with respect to the historical average. Over the past ten years (40 quarters), CRBP's ROE was at its highest in in the December 2023 quarter at 116.17%. The ROE was at its lowest in in the September 2023 quarter at -3232.40%.

Quarterly (TTM)
Annual

Average

-160.48%

Median

-133.87%

Minimum

-1160.42%

Maximum

645.98%

Corbus Pharmaceuticals Holdings, Inc. (CRBP) ROE by Quarter and Year

Discovering the peaks and valleys of Corbus Pharmaceuticals Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 473.71%

Maximum Annual ROE = 645.98%

Minimum Annual Increase = -481.69%

Minimum Annual ROE = -1160.42%

Quarterly (TTM)
Annual
YearROEChange
2024-28.23%-104.37%
2023645.98%-481.69%
2022-169.24%156.76%
2021-65.92%-73.19%
2020-245.84%-78.81%
2019-1160.42%473.71%
2018-202.27%260.49%
2017-56.11%-74.98%
2016-224.22%127.62%
2015-98.51%127.32%

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Average ROE

How has CRBP ROE performed in the past?

The current ROE of Corbus Pharmaceuticals Holdings, Inc. (CRBP) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

149.50%

5-year avg

27.35%

10-year avg

-160.48%

Corbus Pharmaceuticals Holdings, Inc. (CRBP) ROE vs. Peers

How is CRBP’s ROE compared to its peers?

Corbus Pharmaceuticals Holdings, Inc.’s ROE is greater than Applied Therapeutics, Inc. (-65.63%), greater than Elicio Therapeutics, Inc. (-5657.87%), greater than Molecular Partners AG (-50.31%), greater than Cardiff Oncology, Inc. (-77.23%), less than Rani Therapeutics Holdings, Inc. (3.37%), greater than Milestone Pharmaceuticals Inc. (-1885.07%), greater than Forte Biosciences, Inc. (-75.64%), greater than PepGen Inc. (-92.51%), greater than Innate Pharma S.A. (-658.91%), greater than Alector, Inc. (-123.02%),

Build a custom stock screener for Corbus Pharmaceuticals Holdings, Inc. (CRBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corbus Pharmaceuticals Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corbus Pharmaceuticals Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Corbus Pharmaceuticals Holdings, Inc.'s ROE?

How is the ROE calculated for Corbus Pharmaceuticals Holdings, Inc. (CRBP)?

What is the highest ROE for Corbus Pharmaceuticals Holdings, Inc. (CRBP)?

What is the 3-year average ROE for Corbus Pharmaceuticals Holdings, Inc. (CRBP)?

What is the 5-year average ROE for Corbus Pharmaceuticals Holdings, Inc. (CRBP)?

How does the current ROE for Corbus Pharmaceuticals Holdings, Inc. (CRBP) compare to its historical average?